Advanced Asset Management Advisors Inc Bristol Myers Squibb CO Transaction History

Advanced Asset Management Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $1.32 Million - $1.54 Million	24,000 Added 33.9%	94,800 $5.57 Million
Q3 2019 Oct 29, 2019	BUY	$42.77 - $50.71 $855,400 - $1.01 Million	20,000 Added 39.37%	70,800 $3.59 Million
Q2 2019 Aug 02, 2019	BUY	$44.62 - $49.34 $892,400 - $986,800	20,000 Added 64.94%	50,800 $2.3 Million
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $1.39 Million - $1.66 Million	30,800 New	30,800 $1.47 Million
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $1.42 Million - $1.85 Million	-29,200 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$55.19 - $62.25 $44,152 - $49,800	-800 Reduced 2.67%	29,200 $1.81 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $1.8 Million - $1.96 Million	30,000	30,000 $1.84 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Advanced Asset Management Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Advanced Asset Management Advisors Inc with notifications on news.